Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Orbis Medicines

Oral macrocycle drug discovery platform.

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
‌
Morten Graugaard
Country
Denmark
Denmark
CTO
‌
Sevan Habeshian
Email Address
info@orbismedicines.com
Founded Date
2021
Founder
‌
Sevan Habeshian
Headquarters
Copenhagen
Copenhagen
Industry
Health technology
Health technology
Biotechnology
Biotechnology
Investors
‌
Novo A/S
Forbion Capital Partners
Forbion Capital Partners
Eli Lilly
Eli Lilly
NEA (New Enterprise Associates)
NEA (New Enterprise Associates)
Cormorant Asset Management
Cormorant Asset Management
Novo Holdings
Novo Holdings
‌
Export and Investment Fund
Latest Funding Round Date
January 7, 2025
Latest Funding Round Amount (USD)
92,800,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/orbismedicines
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
151,500,000
Official Website
orbismedicines.com

Find more companies like Orbis Medicines

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.